Stock Price Forecast

May 17, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading BIO-TECHNE Corp chart...

About the Company

Bio-Techne Corporation develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.

Exchange

Nasdaq

$1B

Total Revenue

2K

Employees

$13B

Market Capitalization

-2639.86

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TECH News

The Bio-Techne Corp (TECH) Stock expansion path ahead

2d ago, source: bovnews

Scotiabank raised the price target for the Bio-Techne Corp (NASDAQ:TECH) stock to “a Sector outperform”. The rating was released on February 08, 2024, according to finviz. The research report from UBS ...

Bio-Techne Corp

3d ago, source: U.S. News & World Report

Marijuana ETFs have had it rough, but word that cannabis may be reclassified is giving these battered funds new hope.

Bio-Techne Corp. Q3 Profit Decreases, but beats estimates

17d ago, source: Nasdaq

(RTTNews) - Bio-Techne Corp. (TECH) announced earnings for third quarter that decreased from last year but beat the Street estimates. The company's earnings totaled $49.059 million, or $0.31 per ...

Bio-Techne Corp (TECH) Q3 Fiscal 2024 Earnings: Mixed Results Amid Market Challenges

17d ago, source: Yahoo Finance

Warning! GuruFocus has detected 2 Warning Sign with UTHR. On May 1, 2024, Bio-Techne Corp (NASDAQ:TECH) disclosed its financial outcomes for the third quarter of fiscal year 2024, revealing a ...

Bio-Techne Stock (NASDAQ:TECH), Analyst Ratings, Price Targets, Predictions

6mon ago, source: Benzinga.com

Bio-Techne Corp has a consensus price target of $137.43, established from looking at the 35 latest analyst ratings. The last 3 analyst ratings were released from Deutsche Bank, Stifel, and ...

Bio-Techne Corp (TECH) (Q3 2024) Earnings Call Transcript Highlights: Navigating Market ...

16d ago, source: Yahoo Finance

Revenue: $303.4 million, 2% year-over-year organic growth, 3% reported growth. Net Income: Adjusted EPS $0.48, down from $0.53 year-over-year; GAAP EPS $0.31, down from $0.43 year-over-year.

Bio-Techne Corp Common Stock (TECH)

6y ago, source: Nasdaq

The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Our partner, Quotemedia, provides the upcoming ex ...

Bio-Techne Corp BRDR

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Bio-Techne Corp

17d ago, source: Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Bio-Techne Corp TECH

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...